The Journal of Urology
Volume 179, Issue 5 , Pages 2020-2024, May 2008

Mismatch Repair Gene MSH3 Polymorphism is Associated With the Risk of Sporadic Prostate Cancer

Department of Urology, Veterans Affairs Medical Center and University of California at San Francisco, San Francisco, California, and Department of Laboratory Medicine, Yamaguchi University Graduate School of Medicine (YH, YS, NO), Yamaguchi, Japan

Received 9 August 2007 published online 20 March 2008.

Purpose

The mismatch repair system is a DNA repair mechanism that corrects mispaired bases during DNA replication errors. Cancer cells deficient in MMR proteins have a 102 to 103-fold increase in the mutation rate. Single nucleotide polymorphisms of mismatch repair genes have been shown to cause a decrease in DNA repair activity. We hypothesized that mismatch repair gene polymorphism could be a risk factor for prostate cancer and p53 Pro/Pro genotype carriers could influence MSH3 and MSH6 polymorphisms.

Materials and Methods

DNA samples from 110 patients with prostate cancer and 110 healthy controls were analyzed by single strand conformational polymorphism and polymerase chain reaction-restriction fragment length polymorphism to determine the genotypic frequency of 5 polymorphic loci on 2 MMR genes (MSH3 and MSH6) and p53 codon72. The chi-square test was applied to compare genotype frequency between patients and controls.

Results

A significant increase in the G/A+A/A genotype of MSH3 Pro222Pro was observed in patients compared to controls (OR 1.87, 95% CI 1.0–3.5). The frequency of A/G + G/G genotypes of MSH3 exon23 Thr1036Ala also tended to increase in patients (OR 1.57, 95% CI 0.92–2.72). In p53 codon72 Arg/Pro + Pro/Pro carriers the frequency of the AG + GG genotype of MSH3 exon23 was significantly increased in patients compared to controls (OR 2.1, 95% CI 1.05–4.34).

Conclusions

To our knowledge this is the first report of the association of MSH3 gene polymorphisms in prostate cancer. These results suggest that the MSH3 polymorphism may be a risk factor for prostate cancer.

Key Words: prostate, prostatic neoplasms, polymorphism, genetic, DNA mismatch repair gene, genes, p53

Abbreviations and Acronyms: HNPCC, hereditary nonpolyposis colorectal carcinoma, MMR, mismatch repair, PC, prostate cancer, PCR, polymerase chain reaction, RFLP, restriction fragment length polymorphism, SNP, single nucleotide polymorphism, SSCP, single strand conformational polymorphism

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by National Institutes of Health Grants RO1CA101844, RO1AG21418, R01CA111470, R01CA108612, T32-DK07790, a Veterans Affairs REAP award, Merit Review grants (RD) and the Yamada Science Foundation.

PII: S0022-5347(08)00012-8

doi:10.1016/j.juro.2008.01.009

The Journal of Urology
Volume 179, Issue 5 , Pages 2020-2024, May 2008